HEART AND LUNG FAILURE, TRANSPLANTOLOGY The role of statins in chronic heart failure
نویسندگان
چکیده
منابع مشابه
The role of statins in chronic heart failure
PURPOSE OF REVIEW To discuss unresolved issues and recent findings regarding the use of statins in heart failure. RECENT FINDINGS Recent data from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico--Heart Failure and Controlled Rosuvastatin Multinational Trial in Heart Failure suggest that statins did not have any effect on outcome despite significant reduction in low-d...
متن کاملLipophylic Statins in Heart Failure.
Current clinical practice guidelines do not recommend the use of statins in heart failure (HF). This recommendation is supported by 2 trials that studied hydrophilic statins. We conducted a retrospective study of patients admitted with HF between December 2007 and June 2011 to Hospital de Santa Tecla, Spain. The primary objective was to analyze the usefulness of lipophilic statins in these pati...
متن کاملHeart failure: statins for all?
Although there is increasing evidence of benefit in using statins to treat patients with non-ischaemic heart failure, it is not yet possible to recommend the routine use of these drugs in all heart failure patients, irrespective of the aetiology. T he endothelium is an essential structural and functional element of the cardiovascular system and constitutes the largest endocrine system in the or...
متن کاملthe role of type-d personality, social support and self-compassion in prediction of health behaviors in coronary heart disease patients
نظر به اهمیت و تاثیر روزافزون عوامل روانی – اجتماعی در سلامت جسمی و تاثیر عوامل روان شناختی در بروز بیماریهای مختلف از جمله بیماریهای قلبی و عروقی این پژوهش با هدف کلی بررسی ارتباط تیپ شخصیتی d ، حمایت اجتماعی و خود دلسوزی در پیش بینی رفتارهای بهداشتی بیماران کرونر قلبی و تعیین تفاوت بین بیماران کرونر قلبی با و بدون جراحی و افراد سالم در این متغیرها و رفتارهای بهداشتی آنان، انجام گرفت. جامعه آ...
15 صفحه اولStatins and clinical outcomes in heart failure.
HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase inhibitors (statins) are well-established therapies in the prevention and treatment of cardiovascular disease, reducing all-cause mortality and cardiovascular events in many disease states. Studies have also suggested that statins given to patients after myocardial infarction improve event-free survival even in short time frames; however, evide...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Polish Journal of Cardio-Thoracic Surgery
سال: 2014
ISSN: 1731-5530
DOI: 10.5114/kitp.2014.45681